Table 2.
The ICG-related indicators of all the studies.
| ID | Study | ICG R15 (%) | Intraoperative ICG Dose (mg) | Site of Injection | Imaging System |
|---|---|---|---|---|---|
| 1 | Takeshi Aoki | 13 (4–17)/16 (3–32) | NA | Peripheral vein | The PINPOINT Endoscopic Fluorescence Imaging System (Novadaq, Mississauga, ON, Canada) |
| 2 | Yu Zhou | NA | NA | Peripheral vein | The PINPOINT™ imaging system (NOVADAQ, Toronto, Canada). |
| 3 | Peng Zhang | NA | 2.5/2.5 | Peripheral veins and portal veins | The white-light HD mode of Pinpoint endoscopic fluorescence imaging system (Novadaq Technologies Inc., Canada) |
| 4 | Hao Lu | 4.2 (2.1–7.4)/3.7 (2.4–6.7) | NA | Peripheral vein | The PINPOINT PC9000 (NOVADAQ, Canada) endoscopic system |
| 5 | Hao Chen | NA | 0.25-0.5/0.75-1.25 | Peripheral veins and portal veins | NA |
| 6 | Jian Cheng | 5.8 ± 2.2/6.4 ± 1.7 | 2.5 | NA | NA |
| 7 | Shinji Itoh | 7.5 (0.1–45.9)/10.1 (0.1–28.3) | NA | NA | The Visera Elite II (Olympus, Tokyo, Japan) or IMAGE1 S Camera Systems (KARL STORZ, El Segundo, CA, USA) |
| 8 | Wang Jianxi | NA | 0.125-0.25/2.5 | Peripheral veins and portal veins | NA |
| 9 | Fusheng Liu | NA | 0.025-0.25/0.25-0.5 | Peripheral veins and portal veins | The Canadian Pinpoint Novadaq laparoscopic fluorescence imaging system |
| 10 | Yi Zhou | NA | 0.025-0.125/0.125 | Peripheral veins and portal veins | NA |
| 11 | Zhu Wen | 7.65 (6.45–9.58)/6.85 (5.78–8.60) | 2.5 | Peripheral vein | NA |
ICG, indocyanine green; ICG R15, Retention rate of indocyanine green at 15 minutes; NA, not applicable.